Meningitis B Outbreak Triggers Unprecedented Vaccine Demand Across UK
The UK Health Security Agency (UKHSA) has confirmed that several cases in a Kent meningitis outbreak involve the meningitis B strain, triggering a dramatic surge in private vaccine bookings across the country. This development follows reports of 15 total meningitis cases in Kent, with four confirmed as meningitis B, resulting in two fatalities and multiple hospitalisations.
Pharmacy Services Overwhelmed by Demand
Superdrug has reported a staggering 65-fold increase in meningitis vaccine bookings compared to the previous week, with their nurse clinics experiencing unprecedented demand. A Superdrug spokesperson confirmed: "Bookings at our nurse clinics for our meningitis service this week have surged to 65 times the level seen last week."
Multiple pharmacy chains are offering the meningitis B vaccine, though availability and pricing vary significantly:
- Superdrug: Available for children from two months and adults up to age 50, priced at £110 per dose with a recommended course of two to three doses
- Boots: Available for adults and children aged two and over, costing £220 for two doses
- Well Pharmacy: Available for children from two months and adults up to age 50, with doses at £110 each
- Asda: Launched meningitis vaccine service last year with full menB course available for £179.76
Supply Constraints and Access Inequalities
The National Pharmacy Association (NPA) has reported significant supply issues, with many pharmacies unable to obtain new vaccine orders from wholesalers. NPA chairman Olivier Picard explained: "Many pharmacies across the country have reported to us that they have no supplies of meningitis vaccinations and cannot make new orders from wholesalers."
Health experts have raised serious concerns about unequal access to protection. Dr Eliza Gil, clinical lecturer at the London School of Hygiene & Tropical Medicine, stated: "Some families choose to access vaccination privately as it is commercially available on the high street from chemists. This creates a situation where currently we have unequal access based on ability to pay."
University Response and Public Health Measures
A targeted vaccination programme will soon launch for students at the University of Kent's Canterbury Campus Halls of Residence. Meanwhile, public health officials have prioritised antibiotic treatment for those potentially exposed, with hundreds of people who visited Club Chemistry in Canterbury on March 5, 6 or 7 advised to come forward for preventative antibiotics as a precautionary measure.
Professor Andrew Pollard, director of the Oxford Vaccine Group, emphasised: "The absolute priority today is to ensure that those who have been exposed get antibiotics to stop them developing the disease or spreading the B germs to others." He noted that while vaccines are effective when the strain matches, "it takes time for the immune response to kick in after the jab."
NHS Vaccination Programme Gaps
The meningitis B vaccine was introduced for babies as part of the routine childhood immunisation programme in 2015, but the majority of young people born before this date remain unprotected unless they have obtained the jab privately. The charity Meningitis Now has renewed calls for teenagers and young people to receive meningitis B vaccination through the NHS as part of its No Plan B for menB campaign.
On the NHS, the menB jab is currently recommended for babies at eight weeks, with follow-up doses at 12 weeks and a booster at one year. The menACWY vaccine, which protects against four strains of meningococcal bacteria, is offered to teenagers in school and those entering university up to age 25.
The NPA has urged the NHS to commission pharmacies to provide catch-up services for teenagers who missed their menACWY vaccine and called for reforms to the childhood vaccination programme to address current protection gaps.
